Official opening of K.G. Jebsen Center for Parkinsons Disease
In September 2022 the University of Bergen and Haukeland University Hospital celebrated the opening of a new research center for Parkinsons disease.
In March 2022, the Kristian Gerhard Jebsen Foundation announced that Professor Charalampos Tzoulis at the University of Bergen, has been awarded one of two new K. G. Jebsen centers for medical research.
Parkinson’s disease (PD) affects approximately 10 million people worldwide. It is the brain disease with the fastest increase in the number of cases, and the number of affected individuals is expected to double by the year 2040. A lack of understanding of the molecular processes that initiate and drive the progression of the disease means that, as of today, we lack the knowledge needed to develop neuroprotective treatments that can delay, or even stop, the development of the disease. This means that individuals affected by the disease face a future of progressive disability which results in the need for assistance with daily activities and a shortened lifespan.
The main goal of the K. G. The Jebsen center for Parkinson’s disease is to revolutionize the understanding of the disease by redefining and attacking it as multiple disease subgroups with specific – and potentially treatable – mechanisms. “This will enable us to design and test new treatments for different patient subgroups, thus laying the foundation for a tailor-made, personalized medicine. We are going to deliver new treatments.” center leader Professor Tzoulis stated in his initial presentation.
The foundation congratulates the team and wishes the center the best of luck with its important work.
Read more about the center here.
